In the phase III trial, which was stopped early, Entresto proved superior to the ACE inhibitor enalapril ... picking up Promising Innovative Medicine (PIM) status and the next stage will see ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...